CCM
ASBP

CAAS Capital Management’s Aspire Biopharma Holdings, Inc. Common Stock ASBP Stock Holding History

CAAS Capital Management’s Portfolio ASBP Stock Details ASBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-150,000
Closed -$1.58M – 501
2023
Q1 		$1.58M Hold
150,000
– – 0.08% 37
2022
Q4 		$1.55M Hold
150,000
– – 0.09% 57
2022
Q3 		$1.52M Hold
150,000
– – 0.07% 105
2022
Q2 		$1.5M Buy
+150,000
New +$1.5M 0.07% 102